IDP — Innovaderma Share Price
Last trade - 00:00- £8.14m
- £8.01m
- £10.21m
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 3.74 | ||
| Price to Tang. Book | 4.6 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 0.83 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -49.73% | ||
| Return on Equity | -178.13% | ||
| Operating Margin | -16.52% | ||
Financial Summary
| Year End 30th Jun | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | 8.86 | 10.7 | 12.85 | 13.21 | 10.21 | 12 | n/a | 18.86% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | +250.38 | -50.68 | +134.91 | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health Trend(F-Score)
Bankruptcy Score(Z-Score)
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Innovaderma plc is a United Kingdom-based company, which is engaged in the development, distribution and sale of skincare, haircare, beauty and life science products. Its brands include Skinny Tan, Charles + Lee, Roots, Nuthing and Prolong. Skinny Tan is its flagship brand, which offers products, such as tanning mousses, tanning gels, tanning oils, primers, moisturizers and applicators. Charles + Lee offers men's skin care and grooming range products, including hand and body washes, hand creams, face washes, face moisturizers. Roots is its hair care brand, which offers products, such as shampoos, conditioners, spray treatment. Nuthing offers a range of products for hair removal, which includes shimmer hair removal wax, shimmer hair removal jelly, shimmer shave and shower sorbet. Prolong is its life science brand, which is a vibrating medical device for males who suffer from premature ejaculation. It operates in the United Kingdom, Europe, United States, Australasia, Asia and Africa.
Directors
- Last Annual
- June 30th, 2021
- Last Interim
- December 31st, 2021
- Incorporated
- September 19th, 2014
- Public Since
- May 6th, 2015
- No. of Employees
- 38
- Sector
- Personal & Household Products & Services
- Industry
- Consumer Defensives
- Exchange
- London Stock Exchange
- Shares in Issue
- 28,057,825
- Address
- 27 Old Gloucester Street, LONDON, WC1N 3AX
- Web
- https://www.innovaderma.com/
- Phone
- Auditors
- Crowe U.K. LLP
Latest News for IDP
Upcoming Events for IDP
Half Year 2022 Innovaderma PLC Earnings Release
Similar to IDP
Accrol group
London Stock Exchange
Brand Architekts
London Stock Exchange
Byotrol
London Stock Exchange
Cellular Goods
London Stock Exchange
Creightons
London Stock Exchange
FAQ
As of Today at 01:11 UTC, shares in Innovaderma are trading at 29.00p. This share price information is delayed by 15 minutes.
Shares in Innovaderma last closed at 29.00p and the price had moved by -19.44% over the past 365 days. In terms of relative price strength the Innovaderma share price has underperformed the FTSE All Share Index by -21.39% over the past year.
There is no consensus recommendation for this security.
Innovaderma does not currently pay a dividend.
Innovaderma does not currently pay a dividend.
Innovaderma does not currently pay a dividend.
To buy shares in Innovaderma you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of 29.00p, shares in Innovaderma had a market capitalisation of £8.14m.
Here are the trading details for Innovaderma:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: IDP
Based on an overall assessment of its quality, value and momentum Innovaderma is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Innovaderma is 89.13p. That is 207.34% above the last closing price of 29.00p.
Analysts covering Innovaderma currently have a consensus Earnings Per Share (EPS) forecast of £0.01 for the next financial year.
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Innovaderma. Over the past six months, its share price has underperformed the FTSE All Share Index by -8.96%.
As of the last closing price of 29.00p, shares in Innovaderma were trading -15.05% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Innovaderma PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at 29.00p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Innovaderma's directors